BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1532491)

  • 21. Dual effect of synthetic plasmin substrates on plasminogen activation.
    Kolev K; Owen WG; Machovich R
    Biochim Biophys Acta; 1995 Mar; 1247(2):239-45. PubMed ID: 7696314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Actin stimulates plasmin generation by tissue and urokinase-type plasminogen activators.
    Lind SE; Smith CJ
    Arch Biochem Biophys; 1993 Nov; 307(1):138-45. PubMed ID: 8239651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enzymic properties of the neo-plasmin-Val-422 (miniplasmin).
    Christensen U; Sottrup-Jensen L; Magnusson S; Petersen TE; Clemmensen I
    Biochim Biophys Acta; 1979 Apr; 567(2):472-81. PubMed ID: 36160
    [No Abstract]   [Full Text] [Related]  

  • 24. Nonlysine-analog plasminogen modulators promote autoproteolytic generation of plasmin(ogen) fragments with angiostatin-like activity.
    Ohyama S; Harada T; Chikanishi T; Miura Y; Hasumi K
    Eur J Biochem; 2004 Feb; 271(4):809-20. PubMed ID: 14764098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of Leishmania mexicana promastigotes with the plasminogen-plasmin system.
    Avilan L; Calcagno M; Figuera M; Lemus L; Puig J; Rodriguez AM
    Mol Biochem Parasitol; 2000 Oct; 110(2):183-93. PubMed ID: 11071275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-oleoyl heparin inhibits the amidolytic activity of plasmin and urokinase.
    Legras S; Diczhazi C; Moczar M
    Int J Biol Macromol; 1992 Apr; 14(2):97-9. PubMed ID: 1387549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of molecular forms of plasminogen and plasmin-inhibitor complexes in urokinase-activated human plasma.
    Müllertz S; Thorsen S; Sottrup-Jensen L
    Biochem J; 1984 Oct; 223(1):169-77. PubMed ID: 6208893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative study of the promotion of tissue plasminogen activator and pro-urokinase-induced plasminogen activation by fragments D and E-2 of fibrin.
    Liu JN; Gurewich V
    J Clin Invest; 1991 Dec; 88(6):2012-7. PubMed ID: 1836471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assembly of urokinase receptor-mediated plasminogen activation complexes involves direct, non-active-site interactions between urokinase and plasminogen.
    Ellis V; Whawell SA; Werner F; Deadman JJ
    Biochemistry; 1999 Jan; 38(2):651-9. PubMed ID: 9888805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The importance of the preactivation peptide in the two-stage mechanism of human plasminogen activation.
    Walther PJ; Hill RL; McKee PA
    J Biol Chem; 1975 Aug; 250(15):5926-33. PubMed ID: 1150667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding and activation of plasminogen on the surface of osteosarcoma cells.
    Campbell PG; Wines K; Yanosick TB; Novak JF
    J Cell Physiol; 1994 Apr; 159(1):1-10. PubMed ID: 7511144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of staphylokinase concentration of plasminogen activation.
    Arai K; Mimuro J; Madoiwa S; Matsuda M; Sako T; Sakata Y
    Biochim Biophys Acta; 1995 Aug; 1245(1):69-75. PubMed ID: 7654768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasminogen interaction and activation on Streptococcus mutans surface.
    Urdaneta L; Vanegas G; Premoli G; Avilan L
    Oral Microbiol Immunol; 2004 Aug; 19(4):257-61. PubMed ID: 15209997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The interaction between heparin and plasmin on amidolysis.
    Kohn S; Sakurama S; Morioka T; Ito Y; Yasukouchi T; Nakagawa S
    Thromb Haemost; 1979 Dec; 42(4):1261-75. PubMed ID: 161669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of the synergistic effect between oversulfated chondroitin-6-sulfate and lysine or 6-aminohexanoic acid in enhancing the in-vitro activation of glutamic plasminogen by tissue plasminogen activator or urokinase.
    Kouemo S; McMillan E; Doctor V
    Blood Coagul Fibrinolysis; 2010 Jul; 21(5):425-30. PubMed ID: 20445443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasminogen binding sites in normal human skin.
    Burge SM; Marshall JM; Cederholm-Williams SA
    Br J Dermatol; 1992 Jan; 126(1):35-41. PubMed ID: 1311189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Homocysteine and its thiolactone impair plasmin activity induced by urokinase or streptokinase in vitro.
    Kolodziejczyk-Czepas J; Talar B; Nowak P; Olas B; Wachowicz B
    Int J Biol Macromol; 2012 Apr; 50(3):754-8. PubMed ID: 22197896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Features of the interaction between alpha2-antiplasmin and plasminogen/plasmin].
    Hrynenko TV; Iusova OI; Zadorozhna MB; Makohonenko IeM
    Ukr Biokhim Zh (1999); 2002; 74(6):83-90. PubMed ID: 12924019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of human and ovine acrosomal enzymes by tannic acid in vitro.
    Taitzoglou IA; Tsantarliotou M; Zervos I; Kouretas D; Kokolis NA
    Reproduction; 2001 Jan; 121(1):131-7. PubMed ID: 11226036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neutrophils stimulated by apolipoprotein(a) generate fragments that are stronger inhibitors of plasmin formation than apo(a).
    Lamanuzzi LB; Mtairag el M; Pepe G; Anglés-Cano E
    Thromb Haemost; 2004 Nov; 92(5):1066-75. PubMed ID: 15543335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.